Atomo Diagnostics logo
AT1
Health Care Equipment & Services

Atomo Diagnostics

Short interest
0.26%
+0.24 pp 30d
as of 7 Aug 2023
Reported shorts
1.6M
Shares on issue
605.869M

Atomo Diagnostics (AT1) Short Interest

Atomo Diagnostics (ASX:AT1) had 0.26% of shares reported as short positions as of 7 Aug 2023, representing 1,552,633 shares. Atomo Diagnostics operates in the Health Care Equipment & Services industry. Source: ASIC short position report (T+4 delay).

Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.

Price & short interest

About Atomo Diagnostics

Atomo Diagnostics specializes in the design and production of rapid diagnostic test devices, focusing on user-centered design to improve usability and accuracy. The company is recognized for its innovative platforms that simplify testing processes and reduce user errors, positioning it as a leader in the global rapid diagnostics market.

Company profile →

Atomo Diagnostics (ASX:AT1) has 0.26% of its shares on issue reported as short positions as of 7 Aug 2023, or about 1,552,633 shares. Over the past 30 days that figure has risen 0.24 percentage points, and over 90 days it has risen 0.24 percentage points. Its highest recorded short interest was 0.79% in October 2020. AT1 is classified in the Health Care Equipment & Services industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.

Short interest

History & FAQ →

Weekly context: The 10 most shorted ASX stocks — Week 41, 2026.

Strategy fit

How each stock picker strategy reads AT1 today

Prices to 14 Oct 2026 · Mechanical readings of published rules, not recommendations · Not financial adviceFull strategy readings →

AT1 fundamentals

In the year to 30 Jun 2026, Atomo Diagnostics (ASX:AT1) recorded revenue of A$5.2M and a net loss after tax of A$3.5M. A year earlier it recorded revenue of A$3.2M and a net loss after tax of A$5.0M. Year-on-year growth: revenue +60.9% (FY). Net margin −67.2%, return on equity −47.9% (FY). Figures are in AUD, the company's reporting currency; source: Yahoo Finance, as at 2 Oct 2026.

Full statements, ratios and filings are on the Financials tab. Not financial advice.

Full financials →

Company details

address

Level 1, 3-5 George Street, LEICHHARDT, NSW, AUSTRALIA, 2040

Connect

More Health Care Equipment & Services Stocks

Other shorted stocks in this sector

Be the first to discuss AT1

Start a research thread or post the first pulse update